$FTRE

Thakral Anshul sold $1.9M of FTRE

Thakral Anshul (Chief Executive Officer) sold 99,869 shares of Fortrea Holdings Inc. (FTRE) at an average of $19.16 ($19.03–$19.28, $1.91M total) across 2 trades on 2026-08-05.

Original reporting
SEC EDGAR · Thakral Anshul
Published Aug 6, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 7:46 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$FTRE
Neutral
medium confidence
Mentioned
$FTRE
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$FTRENeutralLow
01

Why it matters

The CEO’s open-market sale is new information for traders monitoring insider activity, but it is not accompanied by any new company performance, guidance, or strategic event.

02

Market read

Traders may briefly reassess sentiment around insider selling, but there is no fundamental catalyst in the filing text.

03

What to watch

The filing does not provide intent, tax context, or whether sales were part of broader compensation/vesting activity; without that, price impact should be discounted.

Relevance 6/10Novelty 5/10Timing: SEC Form 4 filed Aug 6, covering Aug 5 sales

Background

The article is an SEC Form 4 insider transaction disclosure for Fortrea Holdings Inc.

Company-level read

Ticker impact

$FTRENeutralMedium confidence
Context

Fortrea CEO Thakral Anshul sold about 99,869 shares in open-market trades totaling $1.91M, per a new SEC Form 4 filed Aug 6.

Expected impact

Likely limited near-term impact; any effect is more sentiment-driven than fundamental.

Evidence & confidence

This is a routine Form 4 insider transaction with no 10b5-1 plan stated, but the article provides no accompanying operational or guidance change.

Market effects

Minimal, as the disclosure is company-specific and does not indicate sector-wide regulatory or demand changes.

None indicated; the event is an insider transaction in a US-listed issuer.

None indicated; no cross-border deal, contract, or regulatory action is described.

Counterpoint

Insider sales can be driven by diversification, taxes, or pre-planned liquidity needs, so the signal may be overstated versus the lack of a stated 10b5-1 plan.

Key entities

  • Fortrea Holdings Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Thakral Anshul

    Fortrea CEO and reporting person who sold shares.

Related articles

$FTREHighAI 9/10

Fortrea Q2 Earnings Call Highlights

"The environment has become more supportive, but our results are not simply the result of market recovery," Thakral said, attributing the performance to changes in commercial execution, including improved global coordination, a sharper focus on opportunities where the company can compete effectively and a clearer approach to serving distinct customer segments. Thakral said Fortrea's clinical pharmacology services business was a particular area of strength.

$FTREMedAI 8/10

Fortrea (NASDAQ:FTRE) Reports Strong Q2 CY2026, Full

Fortrea Holdings (NASDAQ:FTRE) reported Q2 CY2026 revenue of $678.2 million, down 4.5% year over year but 4.7% above market expectations, according to the company. Full-year revenue guidance was $2.66 billion at the midpoint, 1.8% above analysts’ estimates. Non-GAAP EPS was $0.23, 27.2% above consensus.

$FTREMed

Fortrea Holdings Inc. (FTRE): Results of Operations and Financial Condition

Fortrea Holdings Inc. (FTRE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991-pressreleasedat.htm EX-99.1 Document Exhibit 99.1 Fortrea Reports Second Quarter 2026 Results Four consecutive quarters of execution to drive commercial, operational and financial excellence Increases full-year guidance Highlights For the three months ended J

$FTREMedAI 8/10

Fortrea (NASDAQ:FTRE) Trading 10.5% Higher – Should You Buy?

Fortrea Holdings (NASDAQ:FTRE) rose 10.5% in mid-day trading Thursday, reaching $17.20 and last at $17.27, after closing at $15.63. Volume was 886,991 shares, down 42% vs. average. Analysts cited include price targets from $14 to $20. On May 5, Fortrea reported $0.16 EPS vs $0.03 expected and $636.5M revenue vs $628.5M.

$FTREMed

Fortrea (NASDAQ:FTRE) Trading 10.5% Higher – Should You Buy?

Fortrea Holdings (FTRE) rose 10.5% mid-day Thursday, trading between $17.20 and $17.27 after closing at $15.63. Volume was 886,991 shares, down 42% from average. Analysts cited include Mizuho (neutral, $13), Citigroup (buy, $20) and others; consensus is Hold with $17.25 average target. On May 5, Fortrea reported $0.16 EPS and $636.5M revenue.